Overview
- 83 inspections across 81 sites are on record.
- 235 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-06-25.
At a glance
Inspections
83
Sites
81
Observations
235
Career since
Nov 2018
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Cai'e Wang | 25 Jun 2026 | Human Drugs | On file |
| Weiwei Ouyang | 18 Jun 2026 | Human Drugs | On file |
| Biofrontera Discovery GmbH | 7 May 2026 | Human Drugs | View 483 → |
| Comparative Biosciences, Inc | 10 Apr 2026 | Human Drugs | View 483 → |
| Naresh P. Singh, MD | 26 Mar 2026 | Human Drugs | View 483 → |
Sites inspected
Cai'e WangLuoyang, China1 insp.
Weiwei OuyangGuiyang, China1 insp.
Biofrontera Discovery GmbHLeverkusen, Germany1 insp.
Comparative Biosciences, IncSunnyvale, United States1 insp.
Naresh P. Singh, MDLas Vegas, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Kristin M Abaonza3 shared
Jeffrey P Raimondi3 shared
Dustin R Abaonza2 shared
Linda F Murphy2 shared
Andrew R Wasko1 shared
Melkamu Getie Kebtie1 shared
Humberto Z Gomez1 shared
Cynthia J Tsui1 shared
Stephanie Barragan1 shared
Joan T Briones1 shared
Full investigator report
Get the verbatim findings behind Scott N Lim's 235 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site